Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: A comparative study using positron emission tomography

Neuroscience Letters

Volumn 235, Issue 1-2, 1997, Pages 49-52

  Imamura, Toru ^a   Ishii, Kazunari ^a   Sasaki, Masahiro ^a   Kitagaki, Hajime ^a   Yamaji, Shigeru ^a   Hirono, Nobutsugu ^a   Shimomura, Tatsuo ^a   Hashimoto, Mamoru ^a   Tanimukai, Satoshi ^a   Kazui, Hiroaki ^a   Mori, Etsuro ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

Author keywords

18F Fluorodeoxyglucose; Alzheimer's disease; Cerebellum; Dementia with Lewy bodies; Limbic area; Occipital lobe; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; COGNITION; COMPARATIVE STUDY; ELECTROENCEPHALOGRAPHY; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; LEWY BODY; LIMBIC CORTEX; MALE; METABOLIC RATE; OCCIPITAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; DEMENTIA; FEMALE; GLUCOSE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEWY BODIES; MALE; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030782718     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00713-1     Document Type: Article

References (24)

1. Albin R.L., Minoshima S., D'Amato C.J., Frey K.A., Kuhl D.A., Sima A.A.F. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 47:1996;462-466.
2. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
3. Förstl H., Burns A., Luthert P., Cairns N., Levy R. The Lewy-body variant of Alzheimer's disease: clinical and pathological findings. Br. J. Psychiatry. 162:1993;385-392.
4. Friston K.J., Holmes A.P., Worsley K.J., Poline J.P., Frith C.D., Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapping. 2:1995;189-210.
5. Gnanalingham K.K., Byrne E.J., Thornton A. Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndrome. Lancet. 347:1996;696-697.
6. Goto I., Taniwaki T., Hosokawa S., Otsuka M., Ichiya Y., Ichimiya A. Positron emission tomographic (PET) studies in dementia. J. Neurol. Sci. 114:1993;1-6.
7. Hansen L., Salmon D., Galasko D., Masliall E., Katzman R., DeTeresa R., Thal L., Pay M.M., Hofstetter R., Klauber M., Rice V., Butters N., Alford M. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology. 40:1990;1-8.
8. Ishii K., Sasaki M., Kitagaki H., Yamaji S., Sakamoto S., Matsuda K., Mori E. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J. Nucl. Med. 38:1997;925-928.
9. Kosaka K. Diffuse Lewy body disease in Japan. J. Neurol. 237:1990;197-204.
10. Langlaris P.J., Thal L., Hansen L., Galasko D., Alford M., Masliah E. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with or without Lewy bodies. Neurology. 43:1993;1927-1934.
11. Lippa C.F., Smith T.W., Swearer J.M. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann. Neurol. 35:1994;81-88.
12. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Low J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N.H., Ballard C., de Vos R.A.I., Wilcock G.K., Jellinger K.A., Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology. 47:1996;1113-1124.
13. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Standlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
14. Peppard R.F., Wayne Martin W.R., Carr G.D., Grochowski E., Schulzer M., Guttman M., McGeer P.L., Phillips A.G., Tsui J.K.C., Calne D.B. Cerebral glucose metabolism in Parkinson's disease with and without dementia. Arch. Neurol. 49:1992;1262-1268.
15. Perry E.K., Haroutunian V., Davis K.L., Lewy R., Lantos P., Eagger S., Honavar M., Dean A., Griffiths M., McKeith I.G., Perry R.H. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. NeuroReport. 5:1994;747-749.
16. Perry E.K., Morris C.M., Court J.A., Cheng A., Fairbairn A.F., McKeith I.G., Irving D., Brown A., Perry R.H. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience. 64:1995;385-395.
17. Perry, E.K. and Perry, R.H., Altered consciousness and transmitter signalingin Lewy body dementia. In R.H. Perry, I.G. McKeith and E.K. Perry (Eds.), Dementia with Lewy Bodies, Cambridge University Press, Cambridge, 1996, pp. 397-413.
18. Perry R.H., Irving D., Blessed G., Fairbairn A., Perry E.K. Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J. Neurol. Sci. 95:1990;119-139.
19. Phelps M.E., Huang S.C., Hoffmane E.J., Selin C., Sokoloff L., Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose: validation of method. Ann. Neurol. 6:1979;371-388.
20. Salmon D.P., Galasko D., Hansen L., Masliah E., Butters N., Thal L.J., Katzman R. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cognit. 31:1996;148-165.
21. Talairach, J. and Tournoux, P.A., A Co-planar Stereotaxic Atlas of the Human Brain, Thieme, Stuttgart, 1988.
22. Turjanski, N. and Brooks, D.J., Positron emission tomography findings in Parkinson's disease and Lewy body disease. In R.H. Perry, I.G. McKeith and E.K. Perry (Eds.), Dementia with Lewy Bodies, Cambridge University Press, Cambridge, 1996, pp. 145-152.
23. VanderBorght T., Minoshima S., Giordani B., Foster N.L., Frey K.A., Berent S., Albin R.L., Koeppe R.A., Kuhl D.E. Cerebral metabolic differences in Parkinson's and Alzheimer's disease matched for dementia severity. J. Nucl. Med. 38:1997;797-802.
24. Yamamoto T., Imai T. A case of diffuse Lewy body and Alzheimer's diseases with periodic synchronous discharges. J. Neuropathol. Exp. Neurol. 47:1988;536-548.